MarketInOut Stock Screener Log In | Sign Up

COSCIENS Biopharma Inc

TSX • Healthcare • Biotechnology • Quote as of 10/27/2026 10:07
COSCIENS Biopharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTSX
Market Capitalization8.6 mln
Float0.99 mln
Earnings Date11/10/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

1.35
Highly suspicious

Relative Strength

5 / 100
Severely lagging

Debt / Equity

0.13
Very low leverage

Pre-Tax Margin

-53%
Severely loss-making

ROE

83.52
Exceptional

Business Description

COSCIENS Biopharma Inc., formerly known as Aeterna Zentaris Inc., is a Toronto-based life science company founded in 1990 that develops and sells products for the cosmetic, nutritional, and pharmaceutical industries across North America, Europe, and beyond. Its portfolio includes oat-derived ingredients such as beta glucan, oat oil, and avenanthramides, which are used to support health and address inflammation, as well as Macrilen, an oral treatment that stimulates growth hormone production. The company works with a network of licensed partners including Pharmanovia, Davimed GmbH, and the University of Alberta to bring its products to market.

Key Fundamentals

EPS-5.69
ROE83.52
RPS10.94
ROIC-34.34
ROA28.25
Interest Cover-28.19
EBITDA, mln-4.07
EV / EBITDA-0.72
EV / EBIT-0.52
Revenue, mln11.49
EV / Revenue0.25

Quote Details

Last 8.48
Change -0.22 (-2.53%)
Open 8.48
Volume 108
Turnover 915.84
Average Volume 711.86

Financial Ratios

Pre-Tax Profit Margin-53
Leverage Ratio1.27
Current Ratio4.33
Price / Book0.16
Price / Tangible Book0.16
Debt / Equity0.13
Price / Sales0.88

Financial Strength

Altman Z-Score0.26
Piotroski F-Score 5 / 9
Beneish M-Score1.35
Short Ratio0.71
Short % of Float0.05

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.42% 7 / 100   
1 Month 11.43% 93 / 100   
2 Months -5.15% 24 / 100   
6 Months 18.77% 87 / 100   
1 Year -22.13% 14 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog